Wearable Injectors and Connected Devices USA

Following the success of the Wearable Injectors and Connected Devices Europe conference, SAE Media Group will be bringing the conference to Boston to cater to Big Pharma, Biotech and Device Developers in the USA.

As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body injectors and connected devices hold great opportunity. The conference will delve into on-body device design and development, latest advances in connectivity and digital integration of wearable devices, and opportunities for enhancement of user-interface through human factors case studies. The conference will also address challenges in regulations surrounding wearable injectors and connected devices with case studies and an FDA keynote on cybersecurity.

As part of SAE Media Group's leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R and D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in September 2023!

Key Reasons to Attend:
- Discover the latest advances in wearable injector design and development as well as emerging technologies for improved drug delivery
- Understand and gain insight into the regulations surrounding electronic devices and wearable injectors such as labelling requirements and clinical study expectations
- Delve into the digital integration of medical devices for improved user experience and strategies to ensure connected ecosystems are safe with an FDA Cybersecurity update
- Benchmark against connected injector case studies and gain insight into key considerations during development such as battery selection
- Engage in the latest strategies for implementing user centricity into device design to meet patient needs and increase adherence